yingweiwo

Phosphodiesterase(PDE)

Phosphodiesterase(PDE)

Phosphodiesterase (PDE) is any enzyme that breaks a phosphodiester bond.When phosphodiesterase is mentioned, it usually refers to cyclic nucleotide phosphodiesterases, which are discussed below and have significant clinical implications. There are numerous other families of phosphodiesterases, however, including the phospholipases C and D, autotaxin, sphingomyelin phosphodiesterase, DNases, RNases, and restriction endonucleases, in addition to a large number of less well-studied small-molecule phosphodiesterases.A group of enzymes known as cyclic nucleotide phosphodiesterases breaks down the phosphodiester bond in the second messenger molecules cAMP and cGMP. Within subcellular domains, they control the cyclic nucleotide signaling's amplitude, duration, and localization. Therefore, PDEs play a crucial role in controlling the signal transduction process that these second messenger molecules mediate.

Phosphodiesterase(PDE) related products

Structure Cat No. Product Name CAS No. Product Description
Etazolate hydrochloride (SQ 20009; EHT 0202 hydrochloride) V70270 Etazolate hydrochloride (SQ 20009; EHT 0202 hydrochloride) 35838-58-5 Etazolate HCl (SQ 20009) is an orally bioactive and selective inhibitor of phosphodiesterase type 4 (PDE4) with IC50 of 2 μM.
Eurycomanone (Pasakbumin A) V29123 Eurycomanone (Pasakbumin A) 84633-29-4 Eurycomanone promotes spermatogenesis by inhibiting the activity of phosphodiesterase and aromatase enzymes involved in estrogen production.
Fenspiride V70356 Fenspiride 5053-06-5 Fenspiride is an orally bioactive non-steroidal anti-inflammatory agent and an antagonist of H1-histamine receptors.
Flavoxate V2994 Flavoxate 15301-69-6 Flavoxate is an anticholinergic (AChR) agent that binds and inhibits muscarinic receptors, thereby suppressing the micturition reflex and increases urinary bladder capacity by modifying the micturition center in the brain stem.
Gemlapodect (RO554965) V72073 Gemlapodect (RO554965) 1380329-87-2 Gemlapodect (RO554965) is a phosphodiesterase 10A (PDE10A) inhibitor.
Gisadenafil besylate (UK 369003-26) V72025 Gisadenafil besylate (UK 369003-26) 334827-98-4 Gisadenafil besylate (UK 369003-26) is a specific, orally bioactive phosphodiesterase 5 (PDE5) inhibitor (antagonist) with IC50 of 3.6 nM that prevents the degradation of cyclic guanosine monophosphate (cGMP).
GSK 256066 Trifluoroacetate V32938 GSK 256066 Trifluoroacetate 1415560-64-3 GSK256066 Trifluoroacetate (GSK256066; GSK-256066), thetrifluoroacetic acid salt form ofGSK256066, is a novel selective inhibitor of PDE4B (phosphodiesterase 4B) with important biological activity (e.
HA130 V3384 HA130 1229652-21-4 HA130 (HA-130) is a novel, potent and selective inhibitor of autotaxin (ATX, IC50 = 28 nM) with anticancer activity.
Hcyb1 V76937 Hcyb1 Hcyb1 is a selective, orally bioactive PDE2 inhibitor.
Homo Sildenafil V72059 Homo Sildenafil 642928-07-2 Homo Sildenafil is an analog of Sildenafil that works as a phosphodiesterase inhibitor.
Ibudilast-d7-1 (KC-404-d7-1; AV-411-d7-1; MN-166-d7-1) V72051 Ibudilast-d7-1 (KC-404-d7-1; AV-411-d7-1; MN-166-d7-1) 1204192-90-4 Ibudilast-d7-1 is the deuterium labelled form of Ibudilast.
Ilexsaponin B2 (Ilexsaponin B2; Ilex saponin B2) V72040 Ilexsaponin B2 (Ilexsaponin B2; Ilex saponin B2) 108906-69-0 Ilexsaponin B2 is a saponin extracted from Ilex pubescens Hook.
Irsenontrine (E2027) V72027 Irsenontrine (E2027) 1429509-82-9 Irsenontrine (E2027) is an orally bioactive and selective phosphodiesterase 9 (PDE9) inhibitor.
Irsenontrine maleate (E2027 maleate) V72094 Irsenontrine maleate (E2027 maleate) 1630083-70-3 Irsenontrine (E2027) maleate is an orally bioactive and selective phosphodiesterase 9 (PDE9) inhibitor.
Isopedicin V72063 Isopedicin 4431-42-9 Isopedicin potently and concentration-dependently inhibits the production of superoxide anion (O2 U?) in formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP)-activated cells.
ITI-214 phosphate V22773 ITI-214 phosphate 1642303-38-5 ITI-214 is an orally bioavailable, potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.
K-Ras-PDEδ-IN-1 V2209 K-Ras-PDEδ-IN-1 1841464-21-8 K-Ras-PDEδ-IN-1 is a novel and potent competitiveK-Ras-PDEδinhibitor.
Kuraridine (Hypomatrine) V72030 Kuraridine (Hypomatrine) 34981-25-4 Kuraridine is a ketol extract obtained from Sophora flavescens root.
Kushenol B V72060 Kushenol B 99217-64-8 Kushenol B is an isoprenoid flavonoid extracted from S. flavescens and has antibacterial, anti-inflammatory and antioxidant activities.
LEO 39652 V72022 LEO 39652 1445656-91-6 LEO 39652 is a dual-soft PDE4 inhibitor (antagonist) with IC50s of 1.2 nM for PDE4A, 1.2 nM for PDE4B, 3.0 nM for PDE4C, and 3.8 nM for PDE4D.
Contact Us